Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.

Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it.

Subscribe now to stay up to date on the latest episodes and join the conversation shaping the future of cancer research.

Episode #23:

FEATURING: Dr. Web Cavenee, Cancer Genomics Expert

In this episode of All Things Cancer, Dr. Web Cavenee, chair of NFCR’s Scientific Advisory Board, and NFCR President & CEO Dr. Sujuan Ba look back on more than two decades of collaboration, including the evolution of NFCR’s research funding model from supporting individual investigators to backing broader, more transparent, peer-reviewed programs.

Listen Now On: Spotify | Apple Podcasts | YouTube | Amazon Music

Episode #22:

FEATURING: Dr. Lisa Coussens and Collaborator Dr. Elana Fertig on their Unlikely Partnership

An NFCR Grant, designed to fund cross-disciplinary research, brought Lisa Coussens and Elana Fertig together. Collectively, they combine complex breast cancer datasets with the computational tools needed to make sense of them. Tune in to hear them discuss their partnership and more!

Listen Now On: Spotify | Apple | Youtube | Amazon Music

Episode #21:

From Cancer Caregiver to Research Advocate with Tom Clark

In this episode of All Things Cancer, Cancer Caregiver Tom Clark sits down with Dr. Sujuan Ba, NFCR’s President and CEO, to walk through what comes after a cancer diagnosis. Tom talks candidly about grief and the quiet decision to turn it into purpose.

Listen Now On: Spotify | Apple Podcasts | YouTube | Amazon Music

Hosted by NFCR CEO, Sujuan Ba, Ph.D., this compelling series will bring together the entire ecosystem of cancer research—including leading scientists, oncologists, doctors, patient advocates, caregivers, biotech innovators, and survivors—for powerful discussions on the breakthroughs shaping the future of cancer research, treatment, and care.